The table below shows IOVANCE BIOTHERAPEUTICS, INC.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$71.43M
$67.45M
$59.95M
$49.32M
$58.55M
$31.11M
Cost of revenue
$42.50M
$38.48M
$56.66M
$42.72M
$31.52M
$31.37M
Gross profit
-
-
-
-
-
-
R&D
$62.49M
$75.17M
$79.36M
$75.97M
$67.04M
$62.08M
IOVA annual revenue (10-K history)
IOVANCE BIOTHERAPEUTICS, INC. reported annual revenue of $263.50M for fiscal year 2025. That is up 60.6% from $164.07M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
